Maritime Safety

Showing 468 articles
Business

Gilead Sciences Oncology Update After Positive Trodelvy Keytruda Trial Results

Gilead Sciences (NasdaqGS:GILD) reported positive Phase 3 ASCENT-04/KEYNOTE-D19 results for Trodelvy plus Keytruda in first-line metastatic triple-negative breast cancer. Full Phase 3 clinical data were published in a leading medical journal, highlighting efficacy and safety outcomes for the combination regimen. Following these results, Gilead submitted supplemental regulatory filings to the FDA and EMA seeking expanded use of Trodelvy in this setting. For you as an investor, this update...

Business

Brunswick's Strong Q4 and Aggressive Buybacks Fuel Investor Debate on Valuation

Brunswick Corporation (NYSE:BC) delivered robust fourth-quarter results, driven by strength across all segments, particularly its propulsion business. While management expressed optimism for 2026, the company's accelerated share repurchases have sparked a fresh debate among analysts regarding its valuation and the sustainability of its current momentum.